Tem uma queixa contra
uma instituição ou organismo da UE?

Inquéritos estratégicos

Para além das consultas sobre queixas específicas sobre má administração nas instituições da UE, o Provedor de Justiça Europeu tem igualmente poderes para trabalhar proativamente em questões estratégicas mais globais. O Provedor de Justiça Europeu realiza investigações estratégicas por sua própria iniciativa, que têm por objetivo chamar a atenção para assuntos de interesse público e analisar questões sistémicas mais globais que afetam as instituições da UE e o processo democrático de tomada de decisões.

A apresentar 1 - 10 de 835 resultados

Transparency of the bodies involved in preparing Eurogroup meetings

Segunda-Feira | 13 maio 2019

Transparency of the bodies involved in preparing Eurogroup meetings.

Request for an inspection in Strategic inquiry OI/1/2019/EA on transparency of the bodies involved in preparing Eurogroup meetings

Segunda-Feira | 13 maio 2019

Mr Jeppe Tranholm‐Mikkelsen Secretary-General Council of the European Union Strasbourg, 13/05/2019 Strategic inquiry OI/1/2019/EA: Transparency of the bodies involved in preparing Eurogroup meetings Dear Mr Tranholm-Mikkelsen, In 2016, I raised the issue of the lack of transparency of bodies involved in preparing Eurogroup meetings with the Eurogroup President.[1] In the meantime, the Commission h...

Request for an inspection in Strategic inquiry OI/1/2019/EA on transparency of the bodies involved in preparing Eurogroup meetings

Segunda-Feira | 13 maio 2019

Mr Jean Claude Juncker President European Commission Strasbourg, 13/05/2019 Strategic inquiry OI/1/2019/EA: Transparency of the bodies involved in preparing Eurogroup meetings Dear Mr President, In 2016, I raised the issue of the lack of transparency of bodies involved in preparing Eurogroup meetings with the Eurogroup President.[1] In the meantime, the Commission has pointed out that completing t...

Inquérito de iniciativa própria sobre a alegada falta de resposta da Comissão a correspondência respeitante a uma ordem de reembolso

Quarta-Feira | 28 novembro 2018

Inquérito de iniciativa própria sobre a alegada falta de resposta da Comissão a correspondência respeitante a uma ordem de reembolso.

Décision dans l’enquête d’initiative OI/7/2018/JF portant sur l’absence de réponse d’une Délégation de l’UE à la correspondance concernant un projet d’assistance technique dans le domaine de la santé

Sexta-Feira | 03 maio 2019

1. Le 10 novembre 2017, le plaignant a écrit à la Délégation au sujet du projet susmentionné. N’ayant pas reçu de réponse après un an, le plaignant a saisi la Médiatrice européenne. 2. L'équipe du Médiateur chargée de réaliser l’enquête a contacté la Commission européenne. La Délégation a ensuite répondu au plaignant le 18 avril 2019. 3. Une réponse ayant désormais été envoyée, cette plainte est r...

Strategic inquiry into pre‐submission activities organised by the European Medicines Agency (OI/7/2017/KR).

Segunda-Feira | 17 julho 2017

The European Ombudsman, Emily O'Reilly, has opened an inquiry into the pre-submission activities that the European Medicines Agency (EMA) offers to individual medicine developers before the Agency receives applications for marketing authorisations from them.

Report on the meeting with the European Medicines Agency in the European Ombudsman inquiry into pre-submission activities organised by the Agency (OI/7/2017/KR)

Terça-Feira | 19 dezembro 2017

Institution or body concerned: European Medicines Agency Date and time: 28 September 2017, 8:30-11:00, 11:15 - 12:30 Location: 30 Churchill Place, Canary Wharf, London The European Ombudsman represented by: Mr Fergal Ó Regan, Head of Coordination of Public Interest Inquiries; Mr Koen Roovers, Case Handler, Strategic Inquiries Unit. The European Medicines Agency represented by: Stefano Marino, Head...

Letter from the European Ombudsman to the European Medicines Agency opening strategic inquiry OI/7/2017/KR into pre-submission activities organised by the Agency.

Segunda-Feira | 17 julho 2017

Mr Guido Rasi Executive Director European Medicines Agency (EMA) Strasbourg, 17/07/2017 Subject: Strategic inquiry into pre-submission activities organised by the European Medicines Agency (OI/7/2017/KR). Dear Mr Rasi, I have decided to conduct a strategic inquiry, on my own initiative, into the arrangements that the European Medicines Agency (EMA) has in place for engaging with individual medicin...

Strategic inquiry into pre‐submission activities organised by the European Medicines Agency

Segunda-Feira | 17 julho 2017

The European Ombudsman, Emily O'Reilly, has opened an inquiry into the pre-submission activities that the European Medicines Agency (EMA) offers to individual medicine developers before the Agency receives applications for marketing authorisations from them.